Subscribe
AEC Quarterly
No Result
View All Result
  • Big Story
  • Opinion
  • Energy
  • Interviews
  • Africa
  • Investment
  • Big Story
  • Opinion
  • Energy
  • Interviews
  • Africa
  • Investment
No Result
View All Result
AEC Quarterly
No Result
View All Result

Hesitancy arises as U.S. Health Agency questions AstraZeneca vaccine

2 years ago
Reading Time: 2 mins read
Hesitancy over AstraZeneca Vaccine

Hesitancy over AstraZeneca Vaccine

The Data Safety Monitoring Board (DSMB), an independent committee overseeing the trial, has “expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data,” the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said in a statement. The vaccine developed with Oxford University was 79% effective in preventing symptomatic illness in the large trial that also took place in Chile and Peru, according to the data. It was also 100% effective against severe or critical forms of the disease and hospitalization and posed no increased risk of blood clots.

However, more than a dozen European countries halted the use of the AstraZeneca vaccine earlier this month after reports linked it to a rare blood clotting disorder in a very small number of people. Germany and France resumed inoculations after the EU’s drug regulator said last week it was safe, but an opinion poll on Monday showed Europeans remain sceptical about its safety.

Also Read: EU, AU declares AstraZeneca vaccine safe and effective

Related articles

Groundbreaking Malaria Vaccine is ready for use

President Buhari signs historic PIB into Nigeria’s Law

Many African countries that have already received doses of the vaccine have begun to halt vaccination drives. In South Africa, the country’s health ministry confirmed that its reserves of one million doses of the AstraZeneca vaccine are to leave the country as a small trial suggesting the shot offered minimal protection against mild to moderate illness caused by the 501Y.V2 Covid variant dominant in the country put the brakes on the country’s mass inoculation program. Rwanda also got just under 400,000 doses however, the Rwandan government announced it would temporarily suspend the use of the AstraZeneca vaccine; over 1.5 million doses, citing recent fears over potential side effects.

The highly unusual rebuke from federal health officials comes just one day after interim data from the drug maker showed better-than-expected results from the US trial which had been seen as a scientific counter to concerns that have dogged the shot since late last year. This new hesitancy casts fresh doubt on the global vaccination drives.

Tags: AfricaAstraZeneca VaccineUnited States
Share122Tweet77Share31
Previous Post

161m Africans may have Fallen into COVID-19 Induced Poverty- ECA

Next Post

Nigeria obtains $1 billion loan to support MSMEs— Trade Minister

Related Posts

First malaria vaccine rollout commences in Africa
Africa

Groundbreaking Malaria Vaccine is ready for use

September 3, 2021
Nigeria: President Buhari signs historic PIB into Law
Big Story

President Buhari signs historic PIB into Nigeria’s Law

August 17, 2021
Chibok campaign
Big Story

7 Years Later, One More Chibok Girl Returns Home

August 9, 2021
Health services buckle under third wave COVID outbreak in Africa
Covid-19

Africa records 1 million new COVID cases in one month

July 16, 2021
Algeria celebrates Independence Day
Big Story

Here are 5 Things You didn’t Know About Algeria

July 5, 2021
COVID-19 Vaccine
Big Story

Why Can’t Nigeria Produce COVID-19 Vaccines

July 1, 2021

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Post

  • 5 Young African Entrepreneurs to look out for in 2021

    5 Young African Entrepreneurs to look out for in 2021

    317 shares
    Share 127 Tweet 79
  • Meet Cira-O3, Egypt’s COVID-19 Robot Nurse

    313 shares
    Share 125 Tweet 78
  • Winning in the African Oil and Gas Industry

    312 shares
    Share 125 Tweet 78
  • Africa claims Top 3 spots for the Highest Concentration of Women Entrepreneurs in the World

    312 shares
    Share 125 Tweet 78
  • Assessing Africa’s Digital Response Strategy to COVID-19

    311 shares
    Share 124 Tweet 78

Recommended

Kenya receives 880,000 Moderna Vaccines from US

Kenya receives 880,460 Moderna Vaccines donated by the US

August 24, 2021
Organic agriculture in Nigeria

Nigeria stands out in organic agriculture in the West Africa region

April 12, 2021

Sign Up For AEC Quarterly Newsletter

Get our most compelling stories delivered straight to your inbox.

AEC Quarterly

AEC Quarterly is a great read for investors looking for new opportunities with articles and reports exploring growth, creativity and entrepreneurial spirit.

  • Big Story
  • Africa
  • Opinion
  • Energy
  • Finance
  • Interviews
  • Home
  • About
  • Contact
  • Get Featured in AEC Quarterly Magazine

© 2020 AEC Quarterly. All Rights Reserved. Use of this site constitutes acceptance of our, Terms of Use and Privacy Policy.

No Result
View All Result
  • Big Story
  • Opinion
  • Energy
  • Interviews
  • Africa
  • Investment

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

Go to mobile version